Collegium Pharmaceutical Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: COLL
Share price (7/6/26): $37.47
Market cap (7/6/26): $1.215 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 112 pages Equity Purchase Agreement by and Between Corium Therapeutics Holdings, LLC, Corium, LLC and Collegium Pharmaceutical, Inc. Dated as of March 19, 2026

from 8-K 107 pages Certain Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Agreement and Plan of Merger by and Among Collegium Pharmaceutical, Inc., Carrera Merger Sub Inc., Ironshore Therapeutics Inc. and Shareholder Representative Services LLC, as the Securityholders’ Representative (For the Limited Purposes Described Herein) July 28, 2024

from 8-K 104 pages Agreement and Plan of Merger by and Among: Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and Biodelivery Sciences International, Inc. Dated as of February 14, 2022

from SC TO-C 104 pages Agreement and Plan of Merger by and Among: Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and Biodelivery Sciences International, Inc. Dated as of February 14, 2022

from S-1 10 pages Agreement and Plan of Merger

from DRS 10 pages Agreement and Plan of Merger